v3.26.1
Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Segment revenue $ 238,946 $ 1,214 $ 238,917 $ 4,246
Less: Segment expenses        
Cost of revenue 0 11 0 11
Research and development        
Selling, general and administrative 30,196 22,283 53,535 46,227
Restructuring, long-lived assets impairment and related charges, net 0 (172) 0 (182)
Segment and consolidated net income (loss) 80,080 (110,958) (45,615) (231,923)
Reportable Segment        
Segment Reporting [Line Items]        
Segment revenue 238,946 1,214 238,917 4,246
Less: Segment expenses        
Cost of revenue 0 11 0 11
Research and development        
Contract manufacturing 23,967 14,063 59,974 23,399
Personnel 28,512 33,165 60,040 66,883
Clinical costs 22,532 20,361 48,666 40,967
Licenses, collaborations and contingent consideration, net 41,211 11,301 38,402 47,892
Other R&D 19,061 18,619 37,123 37,013
Selling, general and administrative 30,196 22,283 53,535 46,227
Restructuring, long-lived assets impairment and related charges, net 0 (172) 0 (182)
Plus: Other segment items 6,613 7,459 13,208 26,041
Segment and consolidated net income (loss) $ 80,080 $ (110,958) $ (45,615) $ (231,923)